S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
S&P 500   5,248.49
DOW   39,760.08
QQQ   444.83
Stock market today: World shares are mostly higher after S&P 500 sets another record
Best Bear Market Funds: Top 3 Investment Options to Consider
Mid-Cap Stocks to Outperform the Market This Cycle
Is DraftKings A Good Bet Ahead of Q1 Earnings?
How and When to Roll Your Options Positions?
A UK financial trader dubbed the ringleader of an interest rate manipulation scandal loses an appeal
Merck, Cintas rise; GameStop, MiMedx fall, Wednesday, 3/27/2024
NYSE:UPH

UpHealth (UPH) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
$0.27
$0.98
52-Week Range
N/A
Volume
348,700 shs
Average Volume
121,201 shs
Market Capitalization
$5.33 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
UPH stock logo

About UpHealth Stock (NYSE:UPH)

UpHealth, Inc., together with its subsidiaries, operates as a digital health services company in the Americas, Europe, and Asia. The company operates through three segments Integrated Care Management, Virtual Care Infrastructure, and Services segments. The Integrated Care Management segment offers SyntraNet, an integrated health management platform that enables clinical and community-based care teams to share information, coordinate care, manage utilization, and improve health outcomes for individuals and populations. The Virtual Care Infrastructure segment provides the Martti platform, a digital health infrastructure that enables its partners to implement unique, private-label telehealth strategies customized to their specific needs and markets, including integrated telehealth and language access services. Its platform also offers telemedicine, such as telestroke, teleneurology, and telepsychiatry services. The Services segment offers behavioral health and pharmacy services, as well as operates HelloLyf CX platform for digital dispensary services and HelloLyf HX platform for digital hospital services; and provides diagnostic laboratory testing services. UpHealth, Inc. was founded in 2019 and is headquartered in Delray Beach, Florida.

UPH Stock News Headlines

Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
UpHealth completes $180 million sale
GTCR Completes Acquisition of Cloudbreak Health
Top Project Outperforms BTC in 2023…
According to a recently published report… One DeFi protocol boasted gains over 100% during one of the biggest crashes the crypto market has ever seen. And now, this crypto coin is set to soar in the parabolic bull run projected in 2024.
UpHealth (OTC: UPH)
UPHLW UpHealth, Inc. WT EXP 060826
UPHEALTH RESUMES TRADING ON THE NEW YORK STOCK EXCHANGE
UpHealth to Sell Cloudbreak Health to GTCR for $180M
See More Headlines
Receive UPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for UpHealth and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
8/10/2023
Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Health services
Sub-Industry
N/A
Fax
N/A
Employees
611
Year Founded
N/A

Profitability

Net Income
$-223,000,000.00
Pretax Margin
-42.02%

Debt

Sales & Book Value

Annual Sales
$153.15 million
Book Value
$7.05 per share

Miscellaneous

Free Float
10,439,000
Market Cap
$5.33 million
Optionable
Optionable
Beta
0.51
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Martin S. A. Beck J.D. (Age 57)
    M.B.A., CEO & Director
    Comp: $559.65k
  • Dr. Mariya Pylypiv Ph.D. (Age 35)
    Co-Founder & Director
    Comp: $179.29k
  • Dr. Chirinjeev Baboo Kathuria M.B.A. (Age 58)
    M.D., Co-Founder & Director
    Comp: $82.5k
  • Mr. Jay W. Jennings (Age 56)
    Chief Financial Officer
  • Mr. Jeremy Livianu (Age 41)
    Chief Legal & Compliance Officer
  • Mr. Andrew Panos
    Executive Vice President of Telehealth
  • Ms. Lisa Fluxman
    Senior Vice President of Behavioral Health

UPH Stock Analysis - Frequently Asked Questions

Should I buy or sell UpHealth stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for UpHealth in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" UPH shares.
View UPH analyst ratings
or view top-rated stocks.

How were UpHealth's earnings last quarter?

UpHealth, Inc. (NYSE:UPH) released its quarterly earnings data on Thursday, August, 10th. The company reported ($0.40) earnings per share for the quarter, beating the consensus estimate of ($0.46) by $0.06. The company had revenue of $37.82 million for the quarter, compared to the consensus estimate of $32 million. UpHealth had a positive trailing twelve-month return on equity of 12.33% and a negative net margin of 49.08%. During the same period last year, the business earned ($0.90) EPS.

When did UpHealth's stock split?

UpHealth shares reverse split before market open on Friday, December 9th 2022. The 1-10 reverse split was announced on Friday, December 9th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, December 9th 2022. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Who are UpHealth's major shareholders?

UpHealth's stock is owned by many different institutional and retail investors. Top institutional investors include Citadel Advisors LLC (0.00%). Insiders that own company stock include Avi S Katz, Mariya Pylypiv and Neil Miotto.
View institutional ownership trends
.

This page (NYSE:UPH) was last updated on 3/28/2024 by MarketBeat.com Staff

From Our Partners